Page 28 - NZBRI_Annual Report 2017_FA
P. 28

26               New Zealand Brain Research Institute




            NZBRI 2017 Statement of Service Performance












            Reveal new knowledge about the brain

            and its dysfunction




            Output

            Assess new and existing participants in research studies




            Performance Measures                                              Performance


            Quantity         Follow-up existing participants in primary       198 participants assessed
                             longitudinal and imaging Parkinson’s studies     across ~904 visits, 14%

                                                                              fewer than 2016


            Quantity         Gather blood samples for Parkinson’s             160 samples drawn and
                             and control participants for extracting          processed.
                             DNA and other biomarkers.


            Quantity         Continue assessment of participants in           70 participants completed
                             study of cognitive enrichment in Parkinson’s     the protocol. An additional
                             (recruitment commenced in 2015)                  follow-up study will be
                                                                              conducted.


            Quantity         Commence study to use a new PET tracer           Not achieved, 0 of 56
                             to detect tau protein in Parkinson’s disease.    patients recruited (due

                             Total patients required 70, goal to recruit      to international supplier
                             56 in 2016                                       being unable to provide
                                                                              the radioactive PET tracer)


            Quantity         Assess participants in other independent         Study of voluntary
                             sub-studies in Parkinson’s                       suppression of tremor in
                                                                              Parkinson’s disease. Study
                                                                              commenced and completed
                                                                              in 2017: recruited 39
                                                                              patients and completed
                                                                              assessments for 37 (92.5%

                                                                              of planned target of 40).
   23   24   25   26   27   28   29   30   31   32   33